Tappero Stefano, Dell'Oglio Paolo, Cerruto Maria Angela, Sanchez Salas Rafael, Buisan Rueda Oscar, Simone Giuseppe, Hendricksen Kees, Soria Francesco, Umari Paolo, Antonelli Alessandro, Briganti Alberto, Montorsi Francesco, de Cobelli Ottavio, Terrone Carlo, Galfano Antonio, Moschini Marco, Di Trapani Ettore
Department of Urology, IRCCS Policlinico San Martino, Genova, Italy.
Department of Surgical and Diagnostic Integrated Sciences (DISC), University of Genova, Genova, Italy.
Eur Urol Open Sci. 2023 Feb 18;50:47-56. doi: 10.1016/j.euros.2023.01.009. eCollection 2023 Apr.
Head-to-head comparisons between ileal conduit (IC) and orthotopic neobladder (ONB) in terms of peri- and postoperative outcomes and complications, in the specific setting of robot-assisted radical cystectomy (RARC), are not available.
To address the impact of the type of urinary diversion (UD, IC vs ONB) on RARC morbidity, as well as operative time (OT), length of stay (LOS), and readmissions.
Urothelial bladder cancer patients treated with RARC at nine high-volume European institutions between 2008 and 2020 were identified.
RARC with either IC or ONB.
Intra- and postoperative complications were collected and reported according to the Intraoperative Complications Assessment and Reporting with Universal Standards recommendations and European Association of Urology guidelines, respectively. Multivariable logistic regression models tested the impact of UD on outcomes, after adjustment for clustering at single hospital level.
Overall, 555 nonmetastatic RARC patients were identified. In 280 (51%) and 275 (49%) patients, an IC and an ONB were performed, respectively. Eighteen intraoperative complications were recorded. The rates of intraoperative complications were 4% in IC patients and 3% in ONB patients ( = 0.4). The median LOS and readmission rates were 10 versus 12 d ( < 0.001) and 20% versus 21% ( = 0.8) in IC versus ONB patients, respectively. At a multivariable logistic regression analyses, the type of UD (IC vs ONB) reached the independent predictor status for prolonged OT (odds ratio [OR]: 0.61, = 0.03) and prolonged LOS (OR: 0.34, < 0.001), but not for readmission (OR: 0.92, = 0.7). Overall, 513 postoperative complications were experienced by 324 patients (58%). At least one postoperative complication was experienced by 160 (57%) IC patients versus 164 (60%) ONB patients ( = 0.6). The type of UD reached the status of an independent predictor of UD-related complications (OR: 0.64, = 0.03).
Compared with RARC with ONB, RARC with IC is less prone to UD-related postoperative complications, prolonged OT, and prolonged LOS.
To date, the impact of the type of urinary diversion, namely, ileal conduit versus orthotopic neobladder, on peri- and postoperative outcomes of robot-assisted radical cystectomy is unknown. Based on a rigorous data accrual, which relied on established complication reporting systems (Intraoperative Complications Assessment and Reporting with Universal Standards and European Association of Urology recommended systems), we reported intra- and postoperative complications according to urinary diversion type. Moreover, we found that ileal conduit was associated with lower operative time and length of stay, and yielded a protective effect in terms of urinary diversion-related complications.
在机器人辅助根治性膀胱切除术(RARC)的特定背景下,关于回肠膀胱术(IC)和原位新膀胱术(ONB)在围手术期和术后结果及并发症方面的直接比较尚无相关研究。
探讨尿流改道类型(UD,IC对比ONB)对RARC发病率、手术时间(OT)、住院时间(LOS)和再入院率的影响。
设计、设置和参与者:确定了2008年至2020年间在欧洲9家大型机构接受RARC治疗的尿路上皮膀胱癌患者。
行RARC并采用IC或ONB。
分别根据通用标准术中并发症评估和报告建议以及欧洲泌尿外科学会指南收集并报告术中及术后并发症。多变量逻辑回归模型在对单医院层面的聚类进行调整后,测试了UD对结果的影响。
总体而言,共确定了555例非转移性RARC患者。其中,分别有280例(51%)和275例(49%)患者接受了IC和ONB手术。记录到18例术中并发症。IC患者和ONB患者的术中并发症发生率分别为4%和3%(P = 0.4)。IC患者和ONB患者的中位LOS分别为10天和12天(P < 0.001),再入院率分别为20%和21%(P = 0.8)。在多变量逻辑回归分析中,UD类型(IC对比ONB)成为手术时间延长(比值比[OR]:0.61,P = 0.03)和住院时间延长(OR:0.34,P < 0.001)的独立预测因素,但不是再入院的独立预测因素(OR:0.92,P = 0.7)。总体而言,324例患者(58%)经历了513例术后并发症。160例(57%)IC患者和164例(60%)ONB患者至少经历了一种术后并发症(P = 0.6)。UD类型成为UD相关并发症的独立预测因素(OR:0.64,P = 0.03)。
与采用ONB的RARC相比,采用IC的RARC较少发生UD相关的术后并发症、手术时间延长和住院时间延长。
迄今为止,尿流改道类型,即回肠膀胱术与原位新膀胱术,对机器人辅助根治性膀胱切除术围手术期和术后结果的影响尚不清楚。基于严格的数据收集,该研究依赖于既定的并发症报告系统(通用标准术中并发症评估和报告以及欧洲泌尿外科学会推荐系统),我们根据尿流改道类型报告了术中及术后并发症。此外,我们发现回肠膀胱术与较短的手术时间和住院时间相关,并在尿流改道相关并发症方面产生了保护作用。